Loading clinical trials...
Loading clinical trials...
A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF THE LONG-TERM ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB ALONE OR IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) VERSUS NSAIDS ALONE IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP
Conditions
Interventions
NSAID
tanezumab
+5 more
Locations
333
United States
Rheumatology Associates, P.C.
Birmingham, Alabama, United States
Radiant Research
Birmingham, Alabama, United States
Alliance Clinical Research
Birmingham, Alabama, United States
Shades Mountain Imaging
Birmingham, Alabama, United States
Rheumatology Associates of North Alabama, PC
Huntsville, Alabama, United States
Saadat Ansari, MD Office
Huntsville, Alabama, United States
Start Date
February 12, 2009
Primary Completion Date
October 28, 2010
Completion Date
January 12, 2011
Last Updated
June 24, 2021
NCT01422694
NCT06647069
NCT07484243
NCT07295509
NCT07153471
NCT06841562
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions